M
Maneesha
About Maneesha
Data last updated:
Maneesha is a Director at Anvita Tours2health Private Limited (since 2015) and Designated Partner at Guru Daksha Consultancy And Services Llp (since 2016). The companies operate in Healthcare and Information Technology. The largest current company by reported revenue is Anvita Tours2health Private Limited at ₹1.79 Cr (FY 2019).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 10 Dec 2015 | 2009 | ₹1.79 Cr (FY 2019) | Active | |
| Designated Partner | 19 Apr 2016 | 2016 | Active |
Board colleagues of Maneesha
| Name | DIN | Company | Designation |
|---|---|---|---|
| Aneesh Kattungal Ashokan | 00518844 | Anvita Tours2health Private Limited | Director |
| Hemant Radhakrishnan | 02722244 | Anvita Tours2health Private Limited , Guru Daksha Consultancy And Services Llp | Managing Director |
| Rahul Purandiyil Rajendran | 02748494 | Anvita Tours2health Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Maneesha
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Maneesha
Maneesha currently holds 2 directorships: Anvita Tours2health Private Limited (Director, since 10 Dec 2015, revenue ₹1.79 Cr (FY 2019)); Guru Daksha Consultancy And Services Llp (Designated Partner, since 19 Apr 2016).
Maneesha was first appointed on 10 Dec 2015 as Director at Anvita Tours2health Private Limited. The most recent appointment on record is 19 Apr 2016 at Guru Daksha Consultancy And Services Llp.
The current boards of Maneesha's companies include Aneesh Kattungal Ashokan (Anvita Tours2health Private Limited), Hemant Radhakrishnan (Anvita Tours2health Private Limited), Rahul Purandiyil Rajendran (Anvita Tours2health Private Limited).